US EditionPublished • loading... • Updated
WADA Is Investigating If Athletes Are Using GLP-1s For Competitive Advantages And Considering Penalties
Summary by calfkicker.com
This story is only covered by news sources that have yet to be evaluated by the independent media monitoring agencies we use to assess the quality and reliability of news outlets on our platform. Learn more here.1 Articles
1 Articles
WADA Is Investigating If Athletes Are Using GLP-1s For Competitive Advantages And Considering Penalties
A new controversy in the sports world has come up as WADA examines whether weight loss treatments marketed for diabetes and obesity could soon join the prohibited list. According to sources, WADA has confirmed it is actively investigating GLP-1s such as Ozempic and Wegovy to determine if athletes are using these to gain an edge over their competitors. The agency’s findings could lead to a ban before the 2028 Summer Olympics in Los Angeles. Dr. O…
Coverage Details
Total News Sources1
Leaning Left0Leaning Right0Center0Last UpdatedBias DistributionNo sources with tracked biases.
Bias Distribution
- There is no tracked Bias information for the sources covering this story.
Factuality
To view factuality data please Upgrade to Premium
